Digital long-term follow-up for heart disease survivors using HeartCheck
Official title: Digital Long-term Follow-up of Patients With Coronary Artery Disease: a Randomized Controlled Trial
Run by Oslo University Hospital · NCT07720349 · Data updated 2026-11-12
A smartphone-based program called HeartCheck is tested to help adults who survived a recent heart attack or PCI stay on top of risk factors and medications over time.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 630 (estimated) |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 2 sites (Arendal and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | December 31, 2028 |
| Study ends | December 2029 |
| Registry record updated | July 31, 2026 |
| Trial ID | NCT07720349 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 who recently survived an AMI or PCI and own a smartphone or tablet are ideal candidates.
✕Probably not a fit
Patients without access to a compatible device or who have language barriers may be less likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests a digital follow-up solution (HeartCheck) designed to support secondary prevention after an acute myocardial infarction (AMI). Eligible adults with recent AMI or PCI and access to a smartphone participate in a randomized design to see if education, reminders, and clear goal-setting improve risk-factor control and drug adherence during long-term care. The program aims to increase awareness of lifestyle factors and cardiovascular risk and to provide guidance for medication adherence. The study is conducted at Oslo University Hospital and Sorlandet Hospital, with the primary outcome focusing on risk-factor management and adherence, compared with standard care. No phase information is provided.
Why it matters
Potential benefit: If successful, HeartCheck could help patients better manage their risk factors and stay adherent to prescribed therapies after a heart attack.
How similar studies have gone: Digital tools for secondary prevention have shown promise in improving adherence and risk-factor control in some prior studies, but results vary by setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>18 years of age * survived a recent (\<30 days) AMI and/or PCI * access to a smartphone or tablet * signed written informed consent Exclusion Criteria: * patient does not understand Norwegian * patient is unable to comply with the study procedures due to severe comorbidities or high age
Where it's running
-
Sørlandet Hospital Arendal
Arendal, Norway Recruiting -
Oslo University Hospital Ullevål
Oslo, Norway Recruiting
Study contacts
- Principal investigator: Sigrun Halvorsen — Oslo University Hospital
- Study coordinator: Sigrun Halvorsen
- Email: sigruha@uio.no
- Phone: +4722119101
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.